Page 149 - Flipbook January Board
P. 149

Robert Packer Hospital
                                                                                                                Detailed Operating Statement
                                                                                                           For the Period Ending December 31, 2018


                                                                     Month to Date                                                                                    Year to Date
                                                          Actual        Budget      $ Variance                                                             Actual       Budget       $ Variance


                                                          95,952,666    91,925,962    4,026,704                  Patient Service Revenue                  604,352,620  597,798,886     6,553,733
                                                          65,791,797    62,180,150    (3,611,647)           Allowances and Uncollectible Accounts         412,500,419  405,179,316    (7,321,103)
                                                            404,631       695,590       290,959                         Denials                             2,887,778    4,508,428     1,620,651
                                                            173,254       186,628        13,373                       Charity Care                          1,366,928    1,210,783      (156,145)
                                                                 0             0             0                     Insurance Incentives                           0             0            0


                                                          29,582,984    28,863,594      719,389   Patient Service Revenue Net of Contractual and Other Allowances  187,597,495  186,900,360  697,136

                                                           2,132,407     1,935,544     (196,863)                  Provision for Bad Debt                   12,363,287   12,598,217      234,930

                                                          27,450,576    26,928,050      522,527                 Net Patient Service Revenue               175,234,208  174,302,143      932,066
                                                           1,346,508      937,875       408,633               Operating Revenues and Support                6,580,298    5,830,057      750,240
                                                                 0             0             0                  Gain on Retirement of Debt                        0             0            0
                                                          28,797,084    27,865,925      931,159                  Total Operating Revenues                 181,814,506  180,132,200     1,682,306

                                                           6,863,427     7,114,898      251,471                   Salaries - Non-Provider                  41,606,330   44,749,006     3,142,676
                                                                 0             0             0                      Salaries - Provider                           0             0            0
                                                           1,642,482     1,668,400       25,918                     Employee Benefits                      11,333,155   10,632,970      (700,185)
                                                           6,691,981     5,685,453    (1,006,529)                  Purchased Services                      41,338,495   34,605,455    (6,733,040)
                                                           1,673,752     1,668,552       (5,200)                     Physician Fees                        10,770,436   10,174,557      (595,879)
                                                           4,050,229     3,762,835     (287,394)                       Supplies                            25,081,554   24,104,910      (976,643)
                                                           3,155,686     2,500,856     (654,831)                    Pharmaceuticals                        18,830,259   15,711,843    (3,118,417)
                                                            220,513       220,513            0                         Insurance                            1,323,077    1,323,077           0
                                                           1,839,637     1,645,366     (194,272)                     Other Expenses                        12,007,578   10,195,376    (1,812,202)
                                                           1,235,355     1,294,095       58,740                Depreciation and Amortization                7,279,183    8,125,092      845,908
                                                            324,544       313,591       (10,953)                    Interest Expense                        1,952,923    1,941,646       (11,277)
                                                                 0             0             0               Loss on Early Extinguishment of Debt                 0             0            0
                                                                 0             0             0                          Subsidy                                   0             0            0

                                                          27,697,608    25,874,558    (1,823,050)                  Operating Expenses                     171,522,990  161,563,932    (9,959,058)

                                                           1,099,476     1,991,367     (891,890)             Income From Operations before ARO             10,291,516   18,568,268    (8,276,752)
                                                                 0             0             0          Adjustment of Asset Retirement Obligation (ARO)           0             0            0

                                                           1,099,476     1,991,367     (891,890)           Income (Loss) From Operations After ARO         10,291,516   18,568,268    (8,276,752)

                                                           2,339,996      811,613     1,528,383             Investment Interest & Dividend Income           5,521,866    4,966,684      555,181
                                                           1,869,270           0      1,869,270              Gain (Loss) From Sale of Investments          17,654,183           0     17,654,183
                                                         (17,567,737)          0     (17,567,737)           Unrealized Gain (Loss) on Investments         (40,126,745)          0    (40,126,745)
                                                             (90,338)     (93,902)        3,564                    Investment Expense                       (565,314)     (572,234)       6,920
                                                          (1,683,549)          0      (1,683,549)         Change in Fair Value of Derivative Instrument     (440,673)           0       (440,673)
                                                             (75,873)     (77,017)        1,144              Gain (Loss) on Derivative Instrument           (559,956)     (535,718)      (24,238)
                                                                 0             0             0                    Restructuring Expense                           0             0            0
                                                                 0             0             0                    Merger Acquistion Cost                          0             0            0
                                                              (6,409)          0         (6,409)                      Other Gains                                (41)           0           (41)

                                                         (15,214,640)     640,694    (15,855,334)                  Non Operating Gains                    (18,516,680)   3,858,732   (22,375,413)
                                                         (14,115,164)    2,632,060   (16,747,224)          Excess Margin Before Extraordinary Items        (8,225,164)  22,427,001   (30,652,165)

                                                                                             0                     Extraordinary Items                                                       0
                                                         (14,115,164)    2,632,060   (16,747,224)                    Excess Margin                         (8,225,164)  22,427,001   (30,652,165)
   144   145   146   147   148   149   150   151   152   153   154